Baidu
map

肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2017 ACR适宜性标准：卵巢癌筛查

2017-11-14 美国放射学会 ACR官网

卵巢癌筛查

2017年11月，美国放射学会(ACR)发布了关于卵巢癌筛查的适宜性标准。基于当前的可用证据，有很多关于影像检查在卵巢癌筛查中的作用的争论，本文主要讨论了卵巢癌筛查的不同影像检查方式，指出应用盆腔超声筛查高风险人群在某些临床情况下可用。

中文标题：

2017 ACR适宜性标准：卵巢癌筛查

英文标题：

ACR Appropriateness Criteria® Ovarian Cancer Screening.

发布机构：

美国放射学会

发布日期：

2017-11-14

简要介绍：

2017年11月，美国放射学会(ACR)发布了关于卵巢癌筛查的适宜性标准。基于当前的可用证据，有很多关于影像检查在卵巢癌筛查中的作用的争论，本文主要讨论了卵巢癌筛查的不同影像检查方式，指出应用盆腔超声筛查高风险人群在某些临床情况下可用。

 

拓展指南：与卵巢癌相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017 ACR适宜性标准：卵巢癌筛查)] GetToolGuiderByIdResponse(projectId=1, id=4c9ba1c0015253cf, title=2017 ACR适宜性标准：卵巢癌筛查, enTitle=ACR Appropriateness Criteria® Ovarian Cancer Screening., guiderFrom=ACR官网, authorId=null, author=, summary=2017年11月，美国放射学会(ACR)发布了关于卵巢癌筛查的适宜性标准。基于当前的可用证据，有很多关于影像检查在卵巢癌筛查中的作用的争论，本文主要讨论了卵巢癌筛查的不同影像检查方式，指出应用盆腔超声筛查高风险人群在某些临床情况下可用。 , cover=, journalId=null, articlesId=null, associationId=191, associationName=美国放射学会, associationIntro=美国放射学会（American College of Radiology）拥有会员超过34,000名，包括美国放射医师，放射肿瘤学家，物理学家介入医师及核医学医师。其指南按放射检查的方法分类，共十组，每组下包括指南十余篇。同时向NGC提供了近200篇指南。学会拥有《ACR Bulletin》及《JACR》两本官方期刊。, copyright=0, guiderPublishedTime=Tue Nov 14 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>2017年11月，美国放射学会(ACR)发布了关于卵巢癌筛查的适宜性标准。基于当前的可用证据，有很多关于影像检查在卵巢癌筛查中的作用的争论，本文主要讨论了卵巢癌筛查的不同影像检查方式，指出应用盆腔超声筛查高风险人群在某些临床情况下可用。 </P> <P> </P>拓展指南：<strong>与<font color=red>卵巢癌</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=f93ab1c00151951b" title="NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2017.V4）" target=_blank>NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2017.V4）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=77d471c00150828e" title="NCCN临床实践指南：遗传家族高风险评估-乳腺癌和卵巢癌（2018.V1）" target=_blank>NCCN临床实践指南：遗传家族高风险评估-乳腺癌和卵巢癌（2018.V1）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=fb9371c001a963de" title="NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2017.V3）" target=_blank>NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2017.V3）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=68dfd1c001a19e34" title="NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2017.V1）" target=_blank>NCCN临床实践指南：卵巢癌包括输卵管癌和原发性腹膜癌（2017.V1）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=61a681c0013a3e0f" title="2017 NCCN临床实践指南：遗传家族高风险评估-乳腺癌和卵巢癌（2017.V2）" target=_blank>2017 NCCN临床实践指南：遗传家族高风险评估-乳腺癌和卵巢癌（2017.V2）</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E5%8D%B5%E5%B7%A2%E7%99%8C" target=_blank>有关卵巢癌更多指南</a></ul>, tagList=[TagDto(tagId=31318, tagName=卵巢癌筛查)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=21052, categoryName=梅斯医学-卵巢癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4768, appHits=193, showAppHits=0, pcHits=3596, showPcHits=1517, likes=143, shares=6, comments=11, approvalStatus=1, publishedTime=Tue Nov 28 22:17:02 CST 2017, publishedTimeString=2017-11-14, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Nov 28 22:17:02 CST 2017, updatedBy=null, updatedName=null, updatedTime=Tue Jan 02 03:57:48 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 ACR适宜性标准：卵巢癌筛查)])
2017 ACR适宜性标准：卵巢癌筛查
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=265716, encodeId=6c10265e1600, content=谢谢分享学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋，懒，贪, createdTime=Thu Nov 30 16:09:35 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265258, encodeId=f3212652582c, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Nov 29 07:21:50 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265257, encodeId=db4e26525ede, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Nov 29 07:21:35 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265256, encodeId=17f326525668, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Nov 29 07:21:23 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265207, encodeId=7a7f26520e64, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Wed Nov 29 05:47:27 CST 2017, time=2017-11-29, status=1, ipAttribution=)]
    2017-11-30 戒馋，懒，贪

    谢谢分享学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=265716, encodeId=6c10265e1600, content=谢谢分享学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋，懒，贪, createdTime=Thu Nov 30 16:09:35 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265258, encodeId=f3212652582c, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Nov 29 07:21:50 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265257, encodeId=db4e26525ede, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Nov 29 07:21:35 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265256, encodeId=17f326525668, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Nov 29 07:21:23 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265207, encodeId=7a7f26520e64, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Wed Nov 29 05:47:27 CST 2017, time=2017-11-29, status=1, ipAttribution=)]
    2017-11-29 Y—xianghai

    学习了新知识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=265716, encodeId=6c10265e1600, content=谢谢分享学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋，懒，贪, createdTime=Thu Nov 30 16:09:35 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265258, encodeId=f3212652582c, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Nov 29 07:21:50 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265257, encodeId=db4e26525ede, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Nov 29 07:21:35 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265256, encodeId=17f326525668, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Nov 29 07:21:23 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265207, encodeId=7a7f26520e64, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Wed Nov 29 05:47:27 CST 2017, time=2017-11-29, status=1, ipAttribution=)]
    2017-11-29 Y—xianghai

    学习了新知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=265716, encodeId=6c10265e1600, content=谢谢分享学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋，懒，贪, createdTime=Thu Nov 30 16:09:35 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265258, encodeId=f3212652582c, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Nov 29 07:21:50 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265257, encodeId=db4e26525ede, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Nov 29 07:21:35 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265256, encodeId=17f326525668, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Nov 29 07:21:23 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265207, encodeId=7a7f26520e64, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Wed Nov 29 05:47:27 CST 2017, time=2017-11-29, status=1, ipAttribution=)]
    2017-11-29 Y—xianghai

    学习了新知识

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=265716, encodeId=6c10265e1600, content=谢谢分享学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋，懒，贪, createdTime=Thu Nov 30 16:09:35 CST 2017, time=2017-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265258, encodeId=f3212652582c, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Nov 29 07:21:50 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265257, encodeId=db4e26525ede, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Nov 29 07:21:35 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265256, encodeId=17f326525668, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Wed Nov 29 07:21:23 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=265207, encodeId=7a7f26520e64, content=好好好好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Wed Nov 29 05:47:27 CST 2017, time=2017-11-29, status=1, ipAttribution=)]
    2017-11-29 yjs木玉

    好好好好好好好好

    0

Baidu
map
Baidu
map
Baidu
map